Factor | ORa(95% CI) | ||||||
---|---|---|---|---|---|---|---|
Cases with TSGbpromoter hypermethylation | Cases without TSG promoter hypermethylation | ||||||
p16 | DAPK | RARβ | p16 | DAPK | RARβ | ||
CYP1A1 c | GSTM1 d | ||||||
Aa+aa | - | 1.41 | 2.05 | 2.12* | 1.96 | 1.18 | 1.03 |
(0.64-3.08) | (0.94-4.47) | (0.99-4.52) | (0.84-4.59) | (0.50-2.81) | (0.41-2.56) | ||
+ | 0.97 | 1.48 | 1.12 | 1.88 | 1.19 | 1.61 | |
(0.40-2.34) | (0.63-3.47) | (0.47-2.69) | (0.76-4.61) | (0.48-2.97) | (0.66-3.94) | ||
AA | - | 1.44 | 2.14* | 2.07 | 2.64* | 1.69 | 1.75 |
(0.66-3.12) | (0.99-4.63) | (0.97-4.40) | (1.16-5.99) | (0.75-3.82) | (0.76-4.03) | ||
+ | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
(reference) | (reference) | (reference) | (reference) | (reference) | (reference) | ||
Smoking habit | CYP1A1 | ||||||
Yes | Aa+aa | 5.16* | 8.28** | 4.10** | 2.73 | 1.58 | 2.82 |
(1.45-18.35) | (2.38-28.75) | (1.43-11.76) | (0.97-7.64) | (0.54-4.68) | (0.87-9.16) | ||
AA | 4.75* | 6.57** | 3.50* | 2.60 | 2.16 | 3.29 | |
(1.35-16.65) | (1.91-22.64) | (1.22-10.01) | (0.95-7.11) | (0.77-6.02) | (1.07-10.11) | ||
No | Aa+aa | 0.94 | 0.85 | 0.91 | 1.20 | 1.39 | 1.38 |
(0.24-3.68) | (0.25-2.88) | (0.31-2.70) | (0.47-3.08) | (0.52-3.72) | (0.48-3.96) | ||
AA | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
(reference) | (reference) | (reference) | (reference) | (reference) | (reference) | ||
Smoking habit | GSTM1 | ||||||
Yes | - | 17.84** | 17.41** | 8.18** | 4.43** | 2.76 | 4.69* |
(3.10-102.64) | (4.21-72.05) | (2.53-26.49) | (1.54-12.78) | (0.88-8.60) | (1.29-17.05) | ||
+ | 17.62** | 12.29** | 5.14** | 3.09* | 3.35* | 7.10** | |
(3.08-100.91) | (2.95-51.21) | (1.55-17.05) | (1.04-9.14) | (1.08-10.39) | (1.98-25.41) | ||
No | - | 6.18** | 2.81 | 2.47 | 2.24 | 3.00* | 3.68* |
(1.14-33.56) | (0.77-10.20) | (0.79-7.72) | (0.85-2.90) | (1.05-8.55) | (1.15-11.77) | ||
+ | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
(reference) | (reference) | (reference) | (reference) | (reference) | (reference) |